Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Rita Chiari
Impact of TP53 Mutations on Outcome in EGFR -Mutated Patients Treated With First-Line Tyrosine Kinase Inhibitors
Clinical Cancer Research
Cancer Research
Oncology
Crizotinib in MET Deregulated or ROS1 Rearranged Pretreated Non-Small-Cell Lung Cancer (METROS): A Phase II, Prospective, Multicentre, Two-Arms Trial
Clinical Cancer Research
Cancer Research
Oncology
Identification of EML4-ALK Rearrangement and MET Exon 14 R988C Mutation in a Patient With High-Grade Neuroendocrine Lung Carcinoma Who Experienced a Lazarus Response to Crizotinib
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Clinical Outcomes of Patients With Advanced Cancer and Pre‐Existing Autoimmune Diseases Treated With Anti‐Programmed Death‐1 Immunotherapy: A Real‐World Transverse Study
Oncologist
Cancer Research
Medicine
Oncology
Efficacy of Nivolumab in Pre-Treated Non-Small-Cell Lung Cancer Patients Harbouring KRAS Mutations
British Journal of Cancer
Cancer Research
Oncology
Osimertinib in Patients With Advanced Epidermal Growth Factor Receptor T790M Mutation-Positive Non-Small Cell Lung Cancer: Rationale, Evidence and Place in Therapy
Therapeutic Advances in Medical Oncology
Oncology
Preface on “Emerging Treatment Options for Brain Metastases From Non-Small Cell Lung Cancer”
Translational Lung Cancer Research
Oncology
How Might Treatment of ALK-positive Non-Small Cell Lung Cancer Change in the Near Future?
Expert Review of Anticancer Therapy
Oncology
Pharmacology
